Patents by Inventor Sudhirdas K. Prayaga

Sudhirdas K. Prayaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel polypeptides and nucleic acids encoding same
    Publication number: 20020146807
    Abstract: The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: January 29, 2001
    Publication date: October 10, 2002
    Applicant: CuraGen Corporation
    Inventors: Li Li, Sudhirdas K. Prayaga, Muralidhara Padigaru, John R. MacDougall, Kimberly Ann Spytek, Velizar T. Tchernev, Corine A. M. Vernet
  • Polynucleotides and polypeptides encoded thereby
    Publication number: 20020137675
    Abstract: The present invention provides novel polypeptides, termed PROTX polypeptides, as well as polynucleotides encoding PROTX polypeptides and antibodies that immunospecifically bind to a PROTX or a derivative, variant, mutant, or fragment of a PROTX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the PROTX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: February 7, 2001
    Publication date: September 26, 2002
    Inventors: Raymond J. Taupier, Kumud Majumder, Corine Vernet, Sudhirdas K. Prayaga
  • Novel polypeptides and nucleic acids encoding same
    Publication number: 20020107186
    Abstract: The present invention provides novel isolated NOVX polynucleotides and polypeptides encoded by the NOVX polynucleotides. Also provided are the antibodies that immunospecifically bind to a NOVX polypeptide or any derivative, variant, mutant or fragment of the NOVX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the NOVX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: January 4, 2001
    Publication date: August 8, 2002
    Inventors: Sudhirdas K. Prayaga, Kumud Majumder, Bruce Taillon, Steven Kurt Spaderna, Kimberly Spytek, John MacDougall
  • Novel polynucleotides and polypeptides encoded thereby
    Publication number: 20020090692
    Abstract: The present invention provides novel polypeptides, termed PTMAX polypeptides, as well as polynucleotides encoding PTMAX polypeptides and antibodies that immunospecifically bind to PTMAX or a derivative, variant, mutant, or fragment of the PTMAX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the PTMAX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: October 10, 2001
    Publication date: July 11, 2002
    Inventors: Sudhirdas K. Prayaga, Corine Vernet, Richard A. Shimkets, Catherine E. Burgess, Kimberly A. Spytek, Velizar Tchernev, Valerie Gerlach, John R. MacDougall, Isabelle Millet, David J. Stone, Karen Ellerman
  • Novel Proteins and nucleic acids encoding the same
    Publication number: 20020068279
    Abstract: The invention provides novel human transmembrane (NOVTRAN), neuromedin (NOVNEUR), gonadtropin (NOVGON), and interleukin-1 receptor antagonist (NOVINTRA A and B) proteins (NOVX proteins) and isolated nucleic acid molecules encoding the same. Also provided are antibodies that immunospecifically bind to NOVX polypeptides or polynucleotides, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which a NOVX polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states. Also provided are methods of diagnosing and treating a lung disease associated with differential expression of human interleukin-1 epsilon.
    Type: Application
    Filed: December 5, 2000
    Publication date: June 6, 2002
    Applicant: CuraGen Corporation
    Inventors: Catherine Burgess, Sudhirdas K. Prayaga, Richard A. Shimkets, Luca Rastelli, Bryan Zerhusen, Peter Mezes
  • Novel fibroblast growth factor and nucleic acids encoding same
    Publication number: 20020058036
    Abstract: The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.
    Type: Application
    Filed: March 26, 2001
    Publication date: May 16, 2002
    Inventors: Michael Jeffers, Richard A. Shimkets, Sudhirdas K. Prayaga, Ferenc L. Boldog, Meijia Yang, Catherine Burgess, Elma Fernandes, John L. Herrmann, William J. LaRochelle, Henri Lichenstein